HHS announced plans to send the remainder of the antiviral drug remdesivir from the national stockpile to states experiencing a surge of COVID-19 cases, including Arizona, California, Florida and Texas. HHS said it would work with Gilead Sciences, the maker of remdesivir, to determine how additional expected doses will be allocated.
US to send remdesivir to states seeing COVID-19 surge
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.